Neurology clinical trials recruiting in Florida

172 recruiting neurology trials match in Florida. Showing 20.

• A Study of Buntanetap in Participants With PDRecruiting

  Phase 2 / Phase 3 · Annovis Bio Inc. · Aventura, Florida

• Neurologic Stem Cell Treatment StudyRecruiting

  N/A · MD Stem Cells · Coral Springs, Florida

• Impact of Capturing Ictal Events With Ultra-long-term Ambulatory EEG Monitoring With Remote EEG Monitoring System.Recruiting

  N/A · Epitel, Inc. · Tampa, Florida

• A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor FluctuationsRecruiting

  Phase 2 · Appello Pharmaceuticals, Inc. · Boca Raton, Florida

• Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)Recruiting

  Phase 3 · Merck Sharp & Dohme LLC · Jacksonville, Florida

• [18F]PI-2620 Phase 3 Histopathological StudyRecruiting

  Phase 3 · Lantheus Biosciences Ltd. · Hialeah, Florida

• A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's DiseaseRecruiting

  Phase 3 · Hoffmann-La Roche · Atlantis, Florida

• A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet SyndromeRecruiting

  Phase 3 · Epygenix · Kissimmee, Florida

• A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)Recruiting

  Phase 3 · Bristol-Myers Squibb · Miami, Florida

• A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)Recruiting

  Phase 3 · Merck Sharp & Dohme LLC · Fort Lauderdale, Florida

• Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR VariantRecruiting

  Phase 3 · Eidos Therapeutics, a BridgeBio company · Jacksonville, Florida

• Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's DiseaseRecruiting

  Phase 2 · Gateway Institute for Brain Research · Davie, Florida

• A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)Recruiting

  Phase 3 · Bristol-Myers Squibb · Gilbert, Arizona

• Dry Needling in Multiple SclerosisRecruiting

  N/A · University of South Florida · Tampa, Florida

• Real-world Prospective Study on the Use of Anti-CGRP Drugs in MigraineRecruiting

  N/A · Hospital Universitari Vall d'Hebron Research Institute · Miami, Florida

• A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)Recruiting

  Phase 2 · Eli Lilly and Company · Atlantis, Florida

• Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.Recruiting

  Phase 3 · Novartis Pharmaceuticals · Altamonte Springs, Florida

• A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)Recruiting

  Phase 3 · Merck Sharp & Dohme LLC · Altamonte Springs, Florida

• An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)Recruiting

  Phase 2 · Yale University · Aurora, Colorado

• Safety and Tolerability of Patterned Stimulation for DBS in the Home SettingRecruiting

  N/A · University of Florida · Gainesville, Florida

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.